Literature DB >> 11358837

Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.

F Yu1, S B White, Q Zhao, F S Lee.   

Abstract

Hypoxia-inducible factor (HIF)-1alpha is a transcription factor that plays a critical role in regulating genes involved in erythropoiesis and angiogenesis. Recent evidence indicates that the von Hippel-Lindau tumor suppressor protein (VHL) is part of a ubiquitin ligase complex that promotes the degradation of HIF-1alpha under normoxic conditions. Under hypoxic conditions, HIF-1alpha is markedly stabilized. A critical issue in understanding the hypoxic response is the identification of hypoxia-regulated steps. We show here that hypoxia and cobalt treatment modulate the capacity of a HIF-1alpha fragment comprising residues 531-652 to coimmunoprecipitate with VHL. Hypoxia and cobalt both significantly diminish the interaction, and furthermore, normoxia treatment after hypoxia rapidly normalizes it. This HIF-1alpha fragment confers hypoxia and cobalt inducibility on a heterologous protein. Significantly, contained within this fragment is a short 27-residue sequence that behaves identically in all respects noted above. Finally, evidence is provided to show that cobalt and hypoxia both induce a posttranslational modification (or loss of one) in HIF-1alpha that affects its binding to VHL. We propose that dynamic, site-specific interaction of HIF-1alpha with VHL provides one mechanism by which HIF-1alpha can be regulated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358837

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

Review 1.  HIF hydroxylation and the mammalian oxygen-sensing pathway.

Authors:  Michal Safran; William G Kaelin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model.

Authors:  Zachary Spicer; David E Millhorn
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

3.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.

Authors:  P C Mahon; K Hirota; G L Semenza
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

Review 4.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

5.  A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.

Authors:  Patrick R Arsenault; Fei Pei; Rebecca Lee; Heddy Kerestes; Melanie J Percy; Brian Keith; M Celeste Simon; Terence R J Lappin; Tejvir S Khurana; Frank S Lee
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

6.  A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.

Authors:  Melanie J Percy; Paul W Furlow; Philip A Beer; Terence R J Lappin; Mary Frances McMullin; Frank S Lee
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

7.  Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis.

Authors:  Carsten Willam; Norma Masson; Ya-Min Tian; S Aleema Mahmood; Michael I Wilson; Roy Bicknell; Kai-Uwe Eckardt; Patrick H Maxwell; Peter J Ratcliffe; Christopher W Pugh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  A role for IOP1 in mammalian cytosolic iron-sulfur protein biogenesis.

Authors:  Daisheng Song; Frank S Lee
Journal:  J Biol Chem       Date:  2008-02-12       Impact factor: 5.157

Review 9.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

Review 10.  Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function.

Authors:  Sarah R Walmsley; Edwin R Chilvers; Moira K B Whyte
Journal:  Arthritis Res Ther       Date:  2009-04-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.